Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acorda Therapeutics

Request full access

A publicly traded biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders

Town of Orangetown, United StatesFounded 1995Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2006
Outcome tier
Thoroughbred$100M+ revenue

Acorda Therapeutics in the Town of Orangetown ecosystem

Live from Dealroom

The Acorda Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Forward Ventures
  • BayStar Capital
  • Swiss Life

Series B and later7 investors entered at this stage

  • ABN AMRO
  • Easton Capital Investment Group
  • Merrill Lynch
  • MPM BioImpact
  • JP Morgan
  • TVM Capital Life Science
  • Cross Atlantic Partners
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States96.6%
🇮🇳 India2.2%
2 countries shown
Web traffic by country
680 monthly visits
across markets
🇺🇸 United States102.9%
Top 1 markets shown

Patents

Estimated portfolio value
$47M

35 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Acorda Therapeutics was the backer or acquirer, 2012–2016. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Acorda Therapeutics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Acorda Therapeutics's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Acorda Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Acorda Therapeutics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.